Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyureaFrancesca Palandri, Valerio De Stefano, Giulia Benevolo et al.|Leukemia|2025Cited by 6
Treatment strategies and survival after ruxolitinib discontinuation in myelofibrosis patients: The Italian RUX-MF multicenter studyFrancesca Palandri, Elisabetta Abruzzese, Massimo Breccia et al.|Leukemia Research|2025Cited by 4